Department of Health written question – answered at on 2 November 2016.
To ask the Secretary of State for Health, if he will make representations to Gilead to ensure the lowest possible price for Truvada is offered to NHS England in the next Clinical Priorities Advisory Group prioritisation round.
As part of NHS England’s Clinical Priorities Advisory Group process, all suppliers of potential new treatments had the opportunity to offer improvements in affordability and improved value for money prior to the prioritisation process.
NHS England continues to work to encourage suppliers to improve affordability and value for money of all new treatments.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.